Sarcopenia. Muscle wasting and atrophy, not elsewhere classified
Conditions
Interventions
Intervention 1: Intervention group: The experimental group will perform exercises according to the resistance training protocol with whole-body electromyostimulation for eight weeks, with two sessions
Sponsors
Ferdowsi University of Mashhad
Eligibility
Sex/Gender
Female
Age
60 Years to 70 Years
Inclusion criteria
Inclusion criteria: They must have sarcopenia. The candidates must be women. the age of the clients must be between 60 and 70 years old.
Exclusion criteria
Exclusion criteria: The volunteer has a specific underlying condition (diabetes and cardiovascular diseases). The volunteer has been using hormonal medications and specific supplements. The volunteer has engaged in physical activity over the past six months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Follistatin. Timepoint: Follistatin measurement 48 hours before the intervention and 48 hours after the last training session. Method of measurement: Blood test.;Myostatin. Timepoint: myostatin measurement 48 hours before the intervention and 48 hours after the last training session. Method of measurement: Blood test.;Cortisol. Timepoint: Cortisol measurement 48 hours before the intervention and 48 hours after the last training session. Method of measurement: Blood test.;Testosterone. Timepoint: testosterone measurement 48 hours before the intervention and 48 hours after the last training session. Method of measurement: Blood test.;Insulin-like Growth Factor. Timepoint: Insulin-like Growth Factor measurement 48 hours before the intervention and 48 hours after the last training session. Method of measurement: Blood test.;Interleukin-6. Timepoint: Interleukin-6 measurement 48 hours before the intervention and 48 hours after the last training session. Method of measurement: Blood test.;Tumor necrosis factor. Timepoint: Tumor necrosis factor measurement 48 hours before the intervention and 48 hours after the last training session. Method of measurement: Blood test.;Static balance. Timepoint: Measurement of static balance before and after the intervention. Method of measurement: Berg balance scale.;Dynamic balance. Timepoint: Measurement of dynamic balance before and after the intervention. Method of measurement: The Timed Up and Go (TUG).;Sarcopenia index. Timepoint: Measurement of Sarcopenia index before and after the intervention. Method of measurement: Skeletal muscle mass (SMM) by the square of their height.;Functional capacity. Timepoint: Measurement of Functional capacity before and after the intervention. Method of measurement: The Sitting and Rising test (SRT).;Muscle mass percentage. Timepoint: Measurement of Muscle mass percentage before and after the intervention. Method of measurement: Body Composition Analysis.;Fat mass percentage. Timepoint: Measurement of | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHelia Khayyami
Ferdowsi University of Mashhad
Outcome results
None listed